Sector pending / Biological Products, Except Diagnostic SubstancesUpdated 2026-05-10 22:07 UTC

BST/296 stock hub

BST/296 has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

BST/296is not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

361M

Stuttgart Stock Exchange

Market data

Live price

Current market quote for this ticker.

Current price

BST/296

In the news

Latest news · BST/296

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a

P25 n/aP50 n/aP75 n/a

Trailing P/En/a

P25 n/aP50 n/aP75 n/a

ROEn/a

P25 n/aP50 n/aP75 n/a

ROICn/a

P25 n/aP50 n/aP75 n/a

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All BST/296 market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

108

Groups with data

Currency

USD

Showing 108 of 108 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	United States
Country code	DE
Employees	13
Employees Change	4%
Employees Change Percent	44.44
Enterprise value	EUR 372.2M
Exchange	Stuttgart Stock Exchange
Financial currency	USD
First seen	2026-05-10
Industry	Biological Products, Except Diagnostic Substances
Last refreshed	2026-05-10
Market cap	EUR 361M
Price	EUR 0.26
Price currency	EUR
Sic	2836
Symbol	bst/296
Website	https://www.cytodyn.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-9.44%
EV Earnings	-10.92x
P/B ratio	-4.09x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
Net Income	EUR -34.1M
Profit Per Employee	EUR -2.6M
ROA	-67.45
Roa5y	-72.4
ROCE	67.07

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Assets	EUR 15.7M
Cash	EUR 13.2M
Current Assets	EUR 15.6M
Current Liabilities	EUR 42.8M
Debt	EUR 24.4M
Equity	EUR -88.3M
Interest Coverage	-7.21
Liabilities	EUR 103.9M
Long Term Assets	EUR 19,288
Long Term Liabilities	EUR 61.2M
Net Cash	EUR -11.1M
Net Cash By Market Cap	EUR -3.09
Tangible Book Value	EUR -88.3M
Tangible Book Value Per Share	EUR -0.06

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	0.37
Net Working Capital	EUR -40.3M
Quick ratio	0.31
Working Capital	EUR -27.1M

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-9.37%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
50-day SMA	0.24
All Time High	0.38
All Time High Change	-31.22%
All Time High Date	2026-04-20
All Time Low	0.17
All Time Low Change	52.94%
All Time Low Date	2026-01-07
ATR	0.04
High	0.26
High52	0.38
High52 Date	2026-04-20
High52ch	-31.22%
Low	0.25
Low52	0.17
Low52 Date	2026-01-07
Low52ch	52.94%
Ma50ch	7.62%
RSI	50.96
RSI Monthly	0
RSI Weekly	60.9
Sharpe ratio	0.86x
Sortino ratio	1.51
Total Return	-9.37%
Tr1m	4%
Tr1w	3.18%
Tr3m	33.33%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	EUR -18.1M

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	1,287,453,504%
Net Borrowing	-120,410.6
Shares Insiders	0.01%
Shares Institutions	0.02%
Shares Qo Q	1.12%
Shares Yo Y	9.37%
Short Ratio	19.43

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Average Volume	19,601x
Bv Per Share	-0.06
Ch1m	4
Ch1w	3.18
Ch3m	33.33
Change	-7.14%
Change From Open	3.17
Close	0.28
Days Gap	-10
Depreciation Amortization	14,415.4
Earnings Date	2026-08-04
EBIT	EUR -18.1M
EBITDA	EUR -18.1M
EPS	EUR -0.03
F Score	2
Financing CF	14,587,673
Fiscal Year End	May
Founded	2,002
Is Primary Listing	0
Last Report Date	2026-02-28
Ma20	0.27
Ma20ch	-2.07%
Net CF	-630,494
Next Earnings Date	2026-08-04
Open	0.25
Position In Range	100
Ppne	27,982.7
Price Date	2026-05-08
Relative Volume	0.24x
Share Based Comp	1,189,898

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

Does BST/296 pay a dividend?

Capital-return profile for this ticker.

Ownership

Who owns BST/296?

Insider, institutional, and short-interest positioning.

Institutional ownership

+0.0%

Share of float held by funds and institutions

Insider ownership

+0.0%

Stake held by company insiders. Higher generally signals alignment.

Negative means the company is buying back shares.

Technical

BST/296 momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

51.0

Neutral momentum band

Price vs 200-day MA

n/a

50/200-day relationship not available

Beta (5Y)

n/a

Sensitivity to the broader market

Sharpe ratio

0.86

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About BST/296

Hub-level FAQ points readers to the deeper analysis pages.

What is the current bst/296 stock rating?

bst/296 is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full bst/296 analysis?

The full report lives at /stocks/bst/296/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for bst/296?

The latest report frames bst/296 around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the bst/296 page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.